ArticleMolecules (Basel, Switzerland)2022
Biological Activity of Pulcherrimin from the
Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 36 citations in OpenAlex.
- Tripartite Interactions in Biocontrol: Insights for Developing Yeast-Based Strategies.Microorganisms · 2025Review
- Metabolomic Insights into the Antimicrobial Effects ofMolecules (Basel, Switzerland) · 2025Article
- First Report on Antifungal Activity ofJournal of fungi (Basel, Switzerland) · 2025Article
- Potential ofFrontiers in microbiology · 2025Review
- Photoprotective Effects of Yeast Pulcherrimin.Molecules (Basel, Switzerland) · 2024Article
- Yeasts, arthropods, and environmental matrix: a triad to disentangle the multi-level definition of biodiversity.Scientific reports · 2024Article
- Two-Stage Screening ofMicroorganisms · 2024Article
- Wild and partially synanthropic bird yeast diversity, in vitro virulence, and antifungal susceptibility of Candida parapsilosis and Candida tropicalis strains isolated from feces.International microbiology : the official journal of the Spanish Society for Microbiology · 2024Article
- Article
- Competition for Nitrogen Resources: An Explanation of the Effects of a Bioprotective StrainFoods (Basel, Switzerland) · 2024Article
- Natural trait variation across Saccharomycotina species.FEMS yeast research · 2024Review
- Iron Competition as an Important Mechanism of Pulcherrimin-ProducingFoods (Basel, Switzerland) · 2023Article
- Pulcherrimin protects Bacillus subtilis against oxidative stress during biofilm development.NPJ biofilms and microbiomes · 2023Article
- TheMolecules (Basel, Switzerland) · 2023Article
- Natural and engineered cyclodipeptides: Biosynthesis, chemical diversity, and engineering strategies for diversification and high-yield bioproduction.Engineering microbiology · 2023Review
- Bio-protection in oenology byFrontiers in microbiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
Abstract
Pulcherrimin is a secondary metabolite of yeasts belonging to the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.